| |
|
|
|
ENDRA Life Sciences Inc.  
|
|
3.82 -0.15 (-0.04%) |
11-14 14:04 |
|
Open: |
4.01 |
Pre close: |
3.97 |
Target:
|
5.09 
|
|
High: |
4.28 |
Low: |
3.79 |
Resistance:
|
4.36
5.75
|
|
Volume: |
194,579 |
Market Cap: |
21M |
Support:
|
2.11
1.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.19
|
MACD |
MACD(12,26):
|
0.20 |
|
MA(20): |
4.51  |
Signal(12,26,9): |
0.36 |
|
MA(100): |
2.99 |
Stochastic Oscillator |
%K(14,3):
|
10.73 |
|
MA(250): |
2.98 |
%D(3): |
21.65 |
|
Average Volume(K) |
3-Month: |
38866
|
52-Week |
High:
|
5.88 |
|
10-Days: |
55450 |
Low: |
1.55 |
|
RSI |
RSI(14):
|
46.01 |
Change(%): |
68.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-289.9 |
Shares Out. (M) |
3.92 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-221.7 |
Shares Float (M) |
3.78 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.70 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.20 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
5.300 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.73 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.25 |
P/S |
263355008.00 |
|
Operating Margin |
-2622.85 |
Levered Free Cash Flow
(M) |
-3.37 |
P/CF |
-2.44 |
|
|
|
|
|
|
